Although current evidence suggests a potential association between GALP and PCOS-related GDM, further clinical studies are required to elucidate its precise mechanistic role and evaluate its feasibility as either a predictive biomarker or therapeutic target. The gene discussed is GALP; the disease is gestational diabetes.